MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
5.19
-0.18
-3.35%
After Hours: 5.13 -0.06 -1.16% 19:34 07/24 EDT
OPEN
5.40
PREV CLOSE
5.37
HIGH
5.47
LOW
5.06
VOLUME
843.49K
TURNOVER
--
52 WEEK HIGH
13.22
52 WEEK LOW
4.480
MARKET CAP
214.85M
P/E (TTM)
-4.5703
1D
5D
1M
3M
1Y
5Y
1D
RxSight CEO Aziz Mottiwala files initial beneficial ownership statement
PUBT · 1d ago
Weekly Report: what happened at RXST last week (0713-0717)?
Weekly Report · 5d ago
RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?
NASDAQ · 07/17 07:50
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO)
TipRanks · 07/16 10:40
RxSight Names Aziz Mottiwala As CEO And Ron Kurtz As CMO Amid Standalone 2026 Sales Outlook Cut
NASDAQ · 07/16 06:24
RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed
TipRanks · 07/15 20:20
RxSight appoints new CEO
Seeking Alpha · 07/15 20:18
RxSight names Aziz Mottiwala CEO, Ron Kurtz to become chief medical officer
PUBT · 07/15 20:17
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company engaged in providing customized vision to patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.